Palmitoyl Tetrapeptide-7 Peptide
Anti-inflammatory tetrapeptide researched for reducing interleukin-6 (IL-6) secretion. Studied for improving skin firmness and reducing glycation-related aging.
This compound is currently in our development pipeline. Enter your email to be notified when it becomes available for research purchase.
Quick Facts
| SKU | PAL7-001 |
|---|---|
| Purity | ≥98% |
| Physical Form | Lyophilized Powder |
| Storage | Store at -20°C |
What is Palmitoyl Tetrapeptide-7?
Palmitoyl Tetrapeptide-7 reduces IL-6 secretion from endothelial cells by up to 21%. IL-6 is a key pro-inflammatory cytokine involved in skin aging, glycation, and collagen degradation. By reducing chronic low-grade inflammation (inflammaging), it helps preserve dermal matrix integrity.
Frequently Asked Questions
What is inflammaging and how does this peptide address it?
Inflammaging is chronic, low-grade inflammation that increases with age, driven partly by IL-6. Palmitoyl Tetrapeptide-7 reduces IL-6 by ~21%, addressing a root cause of collagen degradation and skin aging.
For laboratory and research use only. Not intended for human or animal consumption. All product information is derived from published preclinical research and does not constitute medical advice or claims.